PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

November 30, 2010

Conditions
Allergic Rhinitis
Interventions
DRUG

WF10

0.5 mg/kg B.W.

DRUG

NaCl Solution

NaCl Solution

Trial Locations (1)

04109

POIS, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nuvo Research GmbH

INDUSTRY

NCT01586468 - PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS | Biotech Hunter | Biotech Hunter